In the leading food processor Vissan, State capital will account for 67.76 per cent of the capital after equitisation. The figures are 90 per cent at Ngọc Đồng Food Co Ltd, 55.68 per cent at HCM City General Material Import Export JSC and 51 per cent at Bình Điền JSC. … [Read more...] about BUSINESS NEWS HEADLINES APRIL 8
Cost feasibility study
In comparison to Italy the population of Việt Nam is larger, 100 million compared to 60 million. Việt Nam has a much younger average age, which might decrease the severity of an outbreak. However, most households have several generations which make it more difficult to protect the elderly, who are more venerable. In addition, the proportion of healthcare personnel and hospital beds per capita in the Vietnamese healthcare system is much less, central hospitals normally are over-crowded resulting in patients often having to share beds. Considering the consequences of a generalised Covid-19 epidemic the forceful preventive measures taken by the Vietnamese authorities are crucial. … [Read more...] about A deadly mix of Covid-19 and superbugs may be the cause of high death rates in Italy – could this also happen in Việt Nam and can it be prevented?
Prof. Tran Binh Giang: Doctors at the hospital recently performed a surgery on a female patient who previously sought medical treatment abroad. She went through a hysterectomy surgery and handled her placenta praevia in Singapore, costing 50,000 USD, but there was a side-effect. … [Read more...] about Vietnamese hospitals to remove bottlenecks to lure foreign patients
Dr. Mark McHale received professional training in genetics, biochemistry and molecular biology at the University of London and the University of East Anglia (UEA UK). From 1986 to 1991, he obtained Ph.D. in molecular biology studying under Professor Richard Oliver and carried out post-doctoral research. Currently, he serves as the Head of R&D, Chief Development Officer and a Founder of ASLAN Pharmaceuticals. He has responsibility for progressing novel small molecule and biological therapies aimed at oncology and inflammation from preclinical development to the end of phase II of clinical trials. … [Read more...] about Great Bay Bio’s 3D Advisory Board Science Committee Welcomes Another New Arrival
President Trump said that the US Food and Drug Administration (FDA) had approved it for treating coronavirus, something the organization has denied. Mr Trump later said that it had been approved for "compassionate use" - which means a doctor can give a drug that is yet to be cleared by the government to a patient in a life-threatening condition. … [Read more...] about Hydroxychloroquine: India agrees to release unproven ‘corona drug’